1. Home
  2. HUBC vs PYPD Comparison

HUBC vs PYPD Comparison

Compare HUBC & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HUBC

Hub Cyber Security Ltd.

BUY

Current Price

$0.15

Market Cap

6.6M

Sector

N/A

ML Signal

BUY

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$5.22

Market Cap

107.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUBC
PYPD
Founded
2017
2008
Country
Israel
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6M
107.0M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
HUBC
PYPD
Price
$0.15
$5.22
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $11.75
AVG Volume (30 Days)
★ 1.1M
96.0K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$3.40
52 Week High
$8.68
$5.73

Technical Indicators

Market Signals
Indicator
HUBC
PYPD
Relative Strength Index (RSI) 35.36 54.36
Support Level $0.11 $4.54
Resistance Level $0.31 $5.58
Average True Range (ATR) 0.11 0.24
MACD -0.05 0.02
Stochastic Oscillator 0.17 92.06

Price Performance

Historical Comparison
HUBC
PYPD

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in developing reliable quality assurance systems that support process and product enhancement and also operates in the industry of secured data fabric. The company serves various organizations and institutions operating in the security, electronics, aviation, telecommunications, and banking. The company has two operating segments: Product and Technology Segment and Professional Services Segment. The majority of revenue comes from the professional services segment, which provides data and cybersecurity and system security and reliability solutions and related services such as consulting, planning, integrating and ongoing servicing of cybersecurity, risk management, reliability and security projects and fully managed corporate cybersecurity services.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: